Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
Aim. To compare efficiency of two regimes of basal therapy with human insulin analogs glargin (Lantus) once daily and detemir (Levemir) twicedaily based on their hypoglycemic action (HbA1c
Main Authors: | Alsu Gafurovna Zalevskaya, Nelli Il'inichna Verbovaya, Tatiana Igorevna Rodionova, Olga Konstantinovna Vikulova, Marina Vladimirovna Shestakova |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2010-06-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/5685 |
Similar Items
-
Maternal and neonatal outcomes with the use of long acting, compared to intermediate acting basal insulin (NPH) for managing diabetes during pregnancy: a systematic review and meta-analysis
by: Jijiao Wang, et al.
Published: (2022-10-01) -
CLINICAL AND ECONOMIC BENEFITS OF HUMAN INSULIN ANALOGUESUSE
by: E. E. Arinina, et al.
Published: (2015-03-01) -
Basal insulin titration algorithms in patients with type 2 diabetes: the simplest is the best (?)
by: V.I. Katerenchuk
Published: (2023-03-01) -
Lantus, the first peakless basal insulin analogue: 10 years of clinical experience in children and adolescents
by: Tamara Leonidovna Kuraeva
Published: (2014-07-01) -
On the safety of insulin Glargine
by: Ivan Ivanovich Dedov, et al.
Published: (2009-09-01)